**Core Concept:** Multiple sebaceous tumors are benign neoplasms originating from the sebaceous glands. They can occur either as solitary or multiple lesions, and are usually associated with a genetic syndrome called **Nevoid Basal Cell Carcinoma Syndrome** (NBCCS). NBCCS is caused by mutations in the **PTCH1** gene, which is a tumor suppressor gene.

**Why the Correct Answer is Right:** The correct answer is **D** because multiple sebaceous tumors are a hallmark feature of Nevoid Basal Cell Carcinoma Syndrome (NBCCS). NBCCS is caused by mutations in the PTCH1 gene, which is involved in regulating the Hedgehog signaling pathway crucial for normal development and tissue homeostasis. The development of multiple sebaceous tumors in NBCCS demonstrates the loss of function of PTCH1 leading to uncontrolled sebaceous cell proliferation.

**Why Each Wrong Option is Incorrect:**

A. **Nevoid Basal Cell Carcinoma Syndrome (NBCCS)**: Although sebaceous tumors are a feature of NBCCS, multiple sebaceous tumors are not exclusive to this syndrome. Other conditions can present with sebaceous tumors, making this option incorrect.

B. **Familial Multiple Sebaceous Neoplasia**: Familial multiple sebaceous neoplasia is a distinct entity characterized by multiple sebaceous tumors, but it is not associated with a genetic syndrome. This option is incorrect as well.

C. **Multiple Sebaceous Neoplasia**: Similar to option B, multiple sebaceous neoplasia is a distinct entity with multiple sebaceous tumors but is not associated with a genetic syndrome. This option is incorrect.

E. **Hedgehog Signaling Pathway**: This option incorrectly suggests that multiple sebaceous tumors are caused by an abnormality in the Hedgehog signaling pathway. While the pathway is involved in NBCCS, the mutations in PTCH1 gene cause the development of multiple sebaceous tumors, not a dysfunction in the Hedgehog signaling pathway itself.

**Clinical Pearl**: NBCCS is a clinically significant condition due to its association with other manifestations such as basal cell carcinomas, keratocyst, and intellectual disability. Early recognition and management of these associated manifestations are crucial for optimal patient care.